Reata Pharmaceuticals (NASDAQ:RETA) reported its Q1 earnings results on Wednesday, May 10, 2023 at 06:40 AM.
Here’s what investors need to know about the announcement.
Earnings
Reata Pharmaceuticals beat estimated earnings by 25.21%, reporting an EPS of $-1.81 versus an estimate of $-2.42.
Revenue was down $719 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.12 which was followed by a 11.77% drop in the share price the next day.
Here’s a look at Reata Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -2.21 | -2.18 | -2.02 | -2.15 |
| EPS Actual | -2.33 | -1.47 | -1.36 | -1.33 |
| Revenue Estimate | 430K | 640K | 1.46M | 1.55M |
| Revenue Actual | 0 | 540K | 762K | 914K |
To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
